Clinical Research Open Access
Copyright ©The Author(s) 2003. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Nov 15, 2003; 9(11): 2574-2578
Published online Nov 15, 2003. doi: 10.3748/wjg.v9.i11.2574
Grading and staging of hepatic fibrosis, and its relationship with noninvasive diagnostic parameters
Lun-Gen Lu, Min-De Zeng, Yi-Min Mao, Ji-Qiang Li, De-Kai Qiu, Ai-Ping Cao, Shanghai Institute of Digestive Disease, Renji Hospital, Shanghai Second Medical University, Shanghai 200001, China
Mo-Bin Wan, Cheng-Zhong Li, Department of Infectious Diseases, Changhai Hospital, Shanghai 200433, China
Jun Ye, Department of Infectious Diseases, Putou District Central Hospital, Shanghai 200062, China
Xiong Cai, Department of Infectious Diseases, Changzheng Hospital, Shanghai 200003, China
Cheng-Wei Chen, Shanghai Liver Diseases Research Center, Nanjing Military Command, Shanghai 200233, China
Ji-Yao Wang, Department of Gastroenterology, Zhongshan Hospital, Shanghai 200032, China
Shan-Ming Wu, Shanghai Infectious Hospital, Shanghai 200085, China
Jin-Shui Zhu, Department of Gastroenterology, Shanghai NO.6 Hospital, Shanghai 200233, China
Xia-Qiu Zhou, Department of Infectious Diseases, Ruijin Hospital, Shanghai 200025, China
Author contributions: All authors contributed equally to the work.
Supported by the Key Project of Shanghai Medical Development Foundation, No.99ZDI001
Correspondence to: Lun-Gen Lu, MD, Shanghai Institute of Digestive Disease, Renji Hospital, Shanghai Second Medical University, Shanghai 200001, China. lulungen@online.sh.cn
Telephone: +86-21-33070834 Fax:+86-21-63364118
Received: April 2, 2003
Revised: June 12, 2003
Accepted: June 19, 2003
Published online: November 15, 2003

Abstract

AIM: To explore the grade and stage of pathology and the relationship between grading and staging of hepatic fibrosis and noninvasive diagnostic parameters.

METHODS: Inflammatory activity and fibrosis of consecutive liver biopsies from 200 patients with chronic liver disease were determined according to the Diagnostic Criteria of Chronic Hepatitis in China, 1995. A comparative analysis was made in these patients comparing serum markers, Doppler ultrasonography, CT and/or MR imaging with the findings of liver biopsy.

RESULTS: With increase of inflammatory activity, the degree of fibrosis also rose. There was a close correlation between liver fibrosis and inflammatory activity. AST, GGT, albumin, albumin/globulin, ALP, AFP, hyaluronic acid, N-terminal procollagen III (P III NP), collagen type IV (Col IV), tissue inhibitors of metalloproteinases-1 (TIMP-1), alpha-2-macroglobulin, natural killer cells (NK), some parameters of Doppler ultrasonography, CT and/or MR imaging were all related to the degree of inflammatory activity. GGT, albumin, albumin/globulin, ALP, AFP, hyaluronic acid, Col IV, TIMP-1, alpha-2- macroglobulin, transforming growth factor-beta 1 (TGFβ1), NK, some parameters of Doppler ultrasonography, CT and/or MR imaging were all related to the staging of fibrosis. By regression analysis, the parameters used in combination to differentiate the presence or absence of fibrosis were age, GGT, the parameter of blood flow of portal vein per minute, the maximum oblique diameter of right liver by B ultrasound, the wavy hepatic surface contour by CT and/or MR. The sensitivity, specificity and accuracy of the above parameters were 80.36%, 86.67%, and 81.10%, respectively.

CONCLUSION: There is close correlation between liver fibrosis and inflammatory activity. The grading and staging of liver fibrosis are related to serum markers, Doppler ultrasonography, CT and/or MR imaging. The combination of the above mentioned noninvasive parameters are quite sensitive and specific in the diagnosis of hepatic fibrosis.




INTRODUCTION

Hepatic fibrosis has been a common response to chronic liver injury and might result in potentially lethal sequelae[1-3]. In chronic liver diseases, determination of stage and activity of the fibrotic process and evaluation of anti-fibrotic treatment required accurate variables, the commonly so-called 'fibrotic markers'[4-11]. Since the value of laboratory test to diagnose liver fibrosis was limited, biopsy has been still the golden criterion of the diagnosis of liver fibrosis and cirrhosis at present[12,13]. But it is an invasive diagnostic method, so its application and further propagation are somewhat limited. Searching for a noninvasive diagnostic approach is an interesting subject both at home and abroad. Although some parameters have been found to have important values in iconography and laboratory tests, they are still far from satisfactory. So it is of great realistic value to explore a credible, specific, and noninvasive diagnostic parameter of liver fibrosis for the prevention and treatment of chronic liver disease[14-28]. Therefore, on the basis of histology of chronic liver diseases, this study was designed to explore the relationship between the grade and stage of pathology, and noninvasive diagnostic parameters. We hoped that we could provide the basis for the noninvasive diagnosis of liver fibrosis, so as to improve the prevention and treatment of liver fibrosis.

MATERIALS AND METHODS
Selection of patients

The study was organized and carried out by Shanghai Cooperative Group of Hepatic Fibrosis Project. The Cooperaitive Group was led by Renji Hospital and Changhai Hospital in Shanghai. Cases collected by the Cooperative Group were 37 from Changhai Hospital, 36 from Renji Hospital, 30 from Putuo District Central Hospital, 22 from Shanghai Liver Disease Center of Nanjing Military Command, 20 from Changzheng Hospital, 14 from Zhongshan Hospital, 11 from Huashan Hospital, 9 from Shibei Hospital, 8 from Shanghai No.6 Hospital, 6 from Shanghai Infectious Disease Hospital, 3 from Ruijin Hospital, 3 from Shanghai No.9 hospital, and 1 from Shanghai No.1 hospital. A total of 200 patients were collected between July and October in 1999 according to both clinical and pathological criteria. There were 156 males and 44 females with an average age of 34 years (range 15-60).

Histological examination

One week after admission, all patients underwent liver puncture biopsy under the guide of B type ultrasound with the 14G Quick-cut needle (8-Light Company, Japan) or Menghini needle. The length of liver specimen was more than 1 cm. The samples were fixed with 10% formaldehyde, paraffin slides were made and stained with hematoxylin-eosin, reticular fiber and collagen fiber according to the grading and staging of Diagnostic Criteria of Chronic Hepatitis in China in 1995[29]. Eleven patients were graded and staged for inflammatory activity and liver fibrosis. Three pathologists read the slide independently. The results were checked with Kappa test by statistical experts. It was shown that the coherence of grading and staging of hepatitis fibrosis was excellent. The pathological diagnosis of liver biopsy was finally made by the Department of Pathology, Medical Collage of Fudan University.

Laboratory tests

Blood and urine routine tests: α-fetoprotein (AFP) and prothrombin time were examined by the Cooperative Units.

Serum biochemical tests: Total bilirubin, indirect bilirubin, alanine aminotransferase (ALT), aspartate aminotransferase (AST), AST/ALT, γ-glutamyl transpeptidase (GGT), alkaline phosphatase (ALP), albumin, albumin/globulin, blood urea nitrogen (BUN), creatinine (Cr), triglyceride, cholersterol, high density lipoprotein and low density lipoprotein were all measured by Shanghai Institute of Digestive Disease.

Markers of hepatitis virus and immunological parameter:HBsAg, Anti-HBs, HBeAg, Anti-HBe, Anti-HBc, HBV- DNA, Anti-HCV, HCV- RNA, CD3+, CD4+, CD8+, natural killer cell (NKC), interleukin-2 (IL-2), and interferon-γ (IFN-γ) were detected by Shanghai Institute of Digestive Disease.

Related liver fibrosis markers: α-2-macroglobulin (α-MA), transferrin, apolipoproteinA1, hyaluronic acid (HA), laminin, N-terminal procollagen III (PIIINP), 7S collagen IV (7S-IV), and transforming growth factor-β1 (TGF-β1) were detected by the Clinical immunology Center of Changzheng Hospital in Shanghai.

Tissue inhibitor of metalloproteinase-1 (TIMP-1) were assayed by Shanghai Hongqiao Medical Reagent Institute.

B ultrasound examination

All B ultrasound examinations of the patients were carried out in Shanghai Institute of Digestive Disease. The patients had empty stomach for 14 h before examination. Two skillful doctors performed the examination with color Doppler ultrasonic instrument (HDI 5000). The results were saved in compact disk, three experts judged the examination results and made the final reports.

CT and/or MR imaging

All CT and/or MR examinations were performed by Ruijin Hospital, Changzheng Hospital, Changhai Hospital, Zhongshan Hospital, and Shanghai No.6 Hospital in the Cooperative Group. CT scanners with PQ-2000 and/or PQ-5000 (Picker Company), Plus-s (Siemens Company), Hispeed Adv (GE Company), and MR scanners with Cyroscan T10-NT (Philips Company), Vision Plus and Magnetron Impact (Siemens Company) were used.

Statistical analysis

All the data were analyzed with SAS software by Statistical Department in Shanghai Second Medical University.

RESULTS
Histological examinations

It was revealed that there was a significantly positive correlation between the inflammatory activity and the staging of liver fibrosis. With increase of inflammatory activity, liver fibrosis became more serious (Table 1).

Table 1 Pathological diagnostic results of 200 liver biopsy samples.
Staging of fibrosisGrading of inflammation
value
1234Totalχ²-valueP-value
01820020278.31E-04
142220064
263326064
39219425
40032326
Total66594827200
Laboratory examinations

Relationship between serum biochemical parameters and the grading of inflammation: Only serum biochemical parameters related to liver inflammation are listed in Table 2.

Table 2 Relationship between serum biochemical parameters and grading of inflammation.
ParameterComparision among groups of inflammation grading
1-21-31-42-32-43-4
RBCbbb
PLTbbb
ASTbbab
GGTabbbb
Albuminbbb
Albumin/globulinbbb
ALPbb
AFPbbbbbb
HAbbbbbb
PIIINPbb
7S-IVabab
TIMP-1aa
α-MAba
NKbaa
IgGbbb
IgG + IgA + IgMbbb

Relationship between serum biochemical parameters and staging of liver fibrosis: Only the serum biochemical parameters related to liver fibrosis are listed in Table 3.

Table 3 Relationship between serum biochemical parameters and staging of liver fibrosis.
ParameterComparision among groups of liver fibrosis staging
0-10-20-30-41-21-31-42-32-43-4
RBCaaaa
GGTbbbbbb
Albuminbbbb
Albumin/globulinbbbb
ALPba
AFPbbbbb
HAbbbbbbbb
7S-IVaaa
TIMP-1abaa
α-MAaba
TGFβ-1aaaa
IgGbbbb
IgG + IgA + IgMbbbb
B ultrasound examinations

Comparison between parameters of ultrasonic 2-D and color Doppler flow image and the groups of inflammation grading: Only the parameters of ultrasonic 2-D and color Doppler flow image related with the groups of inflammation grading are listed in Table 4.

Table 4 Comparison between parameters of ultrasonic 2-D and color Doppler flow image and groups of inflammation grading.
ParameterComparision among groups of inflammation grading
1-21-31-42-32-43-4
Inner diameter of left portal veina
Inner diameter of middle liver veinaa
Inner diameter of right liver veinba
Thickness of gallbladder wallabab
Shape of gallbladderbb
Vertical diameter of spleenabab
Thickness of spleenabab
Diameter of spleen veinba
Thickening of the light dots in liver substancebb
Movement degree along with breathba
Movement degree along with heart beatba
Blood stream velocity in constriction phase of liver arterya
Blood stream velocity in dilation phase of liver arterya

Comparison between parameters of ultrasonic 2-D and color Doppler flow image and groups of liver fibrosis staging: Only the parameters of ultrasonic 2-D and color Doppler flow image related with the groups of liver fibrosis staging are listed in Table 5.

Table 5 Comparison between parameters of ultrasonic 2-D and color Doppler flow image and groups of liver fibrosis staging.
ParameterComparision among groups of liver fibrosis staging
0-10-20-30-41-21-31-42-32-43-4
Thickness of liver capsulea
Maximum oblique diameter of right liverabbb
Tube diameter of portal vein trunkaa
Inner diameter of left portal veinabba
Inner diameter of right portal veinInner diameter of right portal veinaaaa
Thickness of gallbladder wallbbaa
Shape of gallbladerbaaa
Diameter of splenic veinbaa
Vertical diameter of spleenabba
Thickness of spleena
Thickening of the light dots in liver substanceaba
Movement degree along with breathba
Movement degree along with heart beatba
Parameter of blood flow of portal vein per minuteaaaa
CT and/or MR imaging examination

Among the 200 patients who received liver biopsy, 192 patients had CT and/or MR imaging examintion. Twenty cases (10.4%) received both CT and MR imaging examination, 92cases (47.9%) received only CT examination, 80 cases (41.7%) received only MR examination.

The results demonstrated that the longitudinal diameter of the left lobe, volume index, the wavy hepatic surface contour, liver crack widening, size of the gallbladder, thickening of the gallbladder wall, changes like little bursa of peri-gallbladder tube, to and fro diameter of the spleen, and thickness of the spleen were all correlated with the grading of inflammation. The wavy hepatic surface contour, changes like little bursa of peri-gallbladder tube, and the to and fro diameter of the spleen were correlated with the staging of liver fibrosis.

DISCUSSION

At present, the diagnosis of liver fibrosis still depends on pathological examination of liver puncture tissue. Since the procedure is invasive, its application and extensive use in clinical practice are still limited. So great attention has been paid to search for and clinical study of a non-invasive diagnostic parameter for liver fibrosis[15,27,28]. It would not only speed up the study of basic medical theory about liver disease, but also be of value[1,3].

In 1995, a new pathological classification method was carried out in our country[29]. The criteria were established respective to distinguish inflammation from liver fibrosis by grading and staging. Both of them have quantified parameters, which are convenient for statistical analysis. Following these criteria, we compared pathological classification with some non-invasive parameters (serologic and imaging parameters), so as to evaluate the value and significance of different parameters in reflecting pathological changes. In the liver puncture tissue of 200 patients with chronic hepatitis, there was a significant positive correlation between inflammatory activity and staging of liver fibrosis. With the increase of inflammatory activity, liver fibrosis became more serious.

In serology, RBC, PLT, AST, GGT, albumin, albumin/globulin, ALP, AFP, HA, PIIINP, 7S-IV, TIMP-1, α2-MA, NK, etc. had a relationship with inflammatory activity, but GGT, albumin, albumin/globulin, ALP, AFP, HA, 7S-IV, and α2-MA had a relationship with liver fibrosis. So these latter parameters might be used as the parameters of liver fibrosis[5,10,30-34]. With the development of inflammation and fibrosis, the level of HA and 7S-IV rose gradually in different inflammatory grading and liver fibrosis staging. In pathological diagnosis, Stage 1 and Stage 2 indicated mild fibrosis, Stage 3 and Stage 4 indicated severe fibrosis. The accuracy, specificity and sensitivity of HA were 82.9%, 93%, and 56%, respectively. The accuracy, specificity and sensitivity of 7S-IV were 72.4%, 94.3%, and 18%, respectively. To some extent, PIIINP might reflect mild and severe changes of inflammation, but it might not reflect the fibrotic changes. This study revealed that laminin had no diagnostic value either in inflammation or in fibrotic changes. It was found that the level of TGFβ1 and TIMP-1 increased more significantly in inflammation and early stage of fibrosis, indicating that they could reflect the changes of liver inflammation and fibrosis[35-38]. In this study, PIIINP, laminin, transferrin, and apoproteinA1 which were known to have significant diagnostic value, were not confirmed. So, we should do more work to probe into their diagnostic significance. In the following study, we would increase the number of cases to further study the diagnostic value of the related parameters in liver fibrosis and evaluate the efficacy of anti-fibrotic drugs, so as to provide a sound basis for the reasonable combined use of the different parameters, and to improve the specificity, accuracy and sensitivity of noninvasive diagnostic tests for liver fibrosis[3,15,19,28].

With the development of modern medical imaging techniques, ultrasound, CT and MR would be widely used. These methods could significantly improve the diagnosis and differential diagnosis of liver disease[17,18,20-26]. In this study, ultrasound examination indicated that the thickness of liver capsule, maximum oblique diameter of right liver, tube diameter of portal vein trunk, diameter of left portal vein, diameter of right portal vein, thickness of gallbladder wall, thickness of spleen, diameter of splenic vein, parameter of blood stream quantity per minute in portal vein, light dot shape, and shape of gallbladder were correlated with the staging of liver fibrosis. CT and/or MR imaging only revealed that the volume of spleen was correlated with liver fibrosis. The results demonstrated that B ultrasound had more value than CT and/or MR imaging in the diagnosis of liver fibrosis. This of course needs further study. It should be noted that factors such as individual variation, nature of the instrument used, patient's condition at the time of examination and difference of the performer's skill might affect the evaluation of the result[21-24]. At the same time, we should carry out quantitative and/or semi-quantitative research on ultrasonic two-dimensional imaging and Doppler blood stream, so as to increase the sensitivity, specificity and accuracy of the diagnostic parameters.

Footnotes

Edited by Xu JY and Wang XL

References
1.  Botta F, Giannini E, Romagnoli P, Fasoli A, Malfatti F, Chiarbonello B, Testa E, Risso D, Colla G, Testa R. MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: A European study. Gut. 2003;52:134-139.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 231]  [Cited by in F6Publishing: 226]  [Article Influence: 10.8]  [Reference Citation Analysis (0)]
2.  Yang C, Zeisberg M, Mosterman B, Sudhakar A, Yerramalla U, Holthaus K, Xu L, Eng F, Afdhal N, Kalluri R. Liver fibrosis: insights into migration of hepatic stellate cells in response to extracellular matrix and growth factors. Gastroenterology. 2003;124:147-159.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 199]  [Cited by in F6Publishing: 215]  [Article Influence: 10.2]  [Reference Citation Analysis (0)]
3.  Oberti F, Valsesia E, Pilette C, Rousselet MC, Bedossa P, Aubé C, Gallois Y, Rifflet H, Maïga MY, Penneau-Fontbonne D. Noninvasive diagnosis of hepatic fibrosis or cirrhosis. Gastroenterology. 1997;113:1609-1616.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 300]  [Cited by in F6Publishing: 269]  [Article Influence: 10.0]  [Reference Citation Analysis (0)]
4.  Guéchot J, Serfaty L, Bonnand AM, Chazouillères O, Poupon RE, Poupon R. Prognostic value of serum hyaluronan in patients with compensated HCV cirrhosis. J Hepatol. 2000;32:447-452.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 72]  [Cited by in F6Publishing: 75]  [Article Influence: 3.1]  [Reference Citation Analysis (0)]
5.  Hayasaka A, Saisho H. Serum markers as tools to monitor liver fibrosis. Digestion. 1998;59:381-384.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 23]  [Cited by in F6Publishing: 25]  [Article Influence: 1.0]  [Reference Citation Analysis (0)]
6.  Ninomiya T, Yoon S, Hayashi Y, Sugano M, Kumon Y, Seo Y, Shimizu K, Kasuga M. Clinical significance of serum hyaluronic acid as a fibrosis marker in chronic hepatitis C patients treated with interferon-alpha: histological evaluation by a modified histological activity index scoring system. J Gastroenterol Hepatol. 1998;13:68-74.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 26]  [Cited by in F6Publishing: 26]  [Article Influence: 1.0]  [Reference Citation Analysis (0)]
7.  George DK, Ramm GA, Walker NI, Powell LW, Crawford DH. Elevated serum type IV collagen: A sensitive indicator of the presence of cirrhosis in haemochromatosis. J Hepatol. 1999;31:47-52.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 44]  [Cited by in F6Publishing: 46]  [Article Influence: 1.8]  [Reference Citation Analysis (0)]
8.  Murawaki Y, Koda M, Okamoto K, Mimura K, Kawasaki H. Diagnostic value of serum type IV collagen test in comparison with platelet count for predicting the fibrotic stage in patients with chronic hepatitis C. J Gastroenterol Hepatol. 2001;16:777-781.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 57]  [Cited by in F6Publishing: 61]  [Article Influence: 2.7]  [Reference Citation Analysis (0)]
9.  Wang T, Wang B, Liu X. [Correlation of serum markers with fibrosis staging in chronic viral hepatitis]. Zhonghua Binglixue Zazhi. 1998;27:185-190.  [PubMed]  [DOI]  [Cited in This Article: ]
10.  Zheng M, Cai W, Weng H, Liu R. Determination of serum fibrosis indexes in patients with chronic hepatitis and its significance. Chin Med J (. Engl). 2003;116:346-349.  [PubMed]  [DOI]  [Cited in This Article: ]
11.  McHutchison JG, Blatt LM, de Medina M, Craig JR, Conrad A, Schiff ER, Tong MJ. Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology. Consensus Interferon Study Group. J Gastroenterol Hepatol. 2000;15:945-951.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 168]  [Cited by in F6Publishing: 173]  [Article Influence: 7.2]  [Reference Citation Analysis (0)]
12.  Gabrielli GB, Capra F, Casaril M, Squarzoni S, Tognella P, Dagradi R, De Maria E, Colombari R, Corrocher R, De Sandre G. Serum laminin and type III procollagen in chronic hepatitis C. Diagnostic value in the assessment of disease activity and fibrosis. Clin Chim Acta. 1997;265:21-31.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 29]  [Cited by in F6Publishing: 29]  [Article Influence: 1.1]  [Reference Citation Analysis (0)]
13.  Castera L, Hartmann DJ, Chapel F, Guettier C, Mall F, Lons T, Richardet JP, Grimbert S, Morassi O, Beaugrand M. Serum laminin and type IV collagen are accurate markers of histologically severe alcoholic hepatitis in patients with cirrhosis. J Hepatol. 2000;32:412-418.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 40]  [Cited by in F6Publishing: 42]  [Article Influence: 1.8]  [Reference Citation Analysis (0)]
14.  Stickel F, Urbaschek R, Schuppan D, Poeschl G, Oesterling C, Conradt C, McCuskey RS, Simanowski UA, Seitz HK. Serum collagen type VI and XIV and hyaluronic acid as early indicators for altered connective tissue turnover in alcoholic liver disease. Dig Dis Sci. 2001;46:2025-2032.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 42]  [Cited by in F6Publishing: 46]  [Article Influence: 2.0]  [Reference Citation Analysis (0)]
15.  Pilette C, Rousselet MC, Bedossa P, Chappard D, Oberti F, Rifflet H, Maïga MY, Gallois Y, Calès P. Histopathological evaluation of liver fibrosis: quantitative image analysis vs semi-quantitative scores. Comparison with serum markers. J Hepatol. 1998;28:439-446.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 154]  [Cited by in F6Publishing: 146]  [Article Influence: 5.6]  [Reference Citation Analysis (0)]
16.  Persico M, Palmentieri B, Vecchione R, Torella R, de SI. Diagnosis of chronic liver disease: reproducibility and validation of liver biopsy. Am J Gastroenterol. 2002;97:491-492.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 35]  [Cited by in F6Publishing: 38]  [Article Influence: 1.7]  [Reference Citation Analysis (0)]
17.  Wachsberg RH, Bahramipour P, Sofocleous CT, Barone A. Hepatofugal flow in the portal venous system: pathophysiology, imaging findings, and diagnostic pitfalls. Radiographics. 2002;22:123-140.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 87]  [Cited by in F6Publishing: 68]  [Article Influence: 3.1]  [Reference Citation Analysis (0)]
18.  Colli A, Fraquelli M, Andreoletti M, Marino B, Zuccoli E, Conte D. Severe liver fibrosis or cirrhosis: Accuracy of US for detection--analysis of 300 cases. Radiology. 2003;227:89-94.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 231]  [Cited by in F6Publishing: 220]  [Article Influence: 10.5]  [Reference Citation Analysis (0)]
19.  Tran A, Hastier P, Barjoan EM, Demuth N, Pradier C, Saint-Paul MC, Guzman-Granier E, Chevallier P, Tran C, Longo F. Non invasive prediction of severe fibrosis in patients with alcoholic liver disease. Gastroenterol Clin Biol. 2000;24:626-630.  [PubMed]  [DOI]  [Cited in This Article: ]
20.  Aubé C, Oberti F, Korali N, Namour MA, Loisel D, Tanguy JY, Valsesia E, Pilette C, Rousselet MC, Bedossa P. Ultrasonographic diagnosis of hepatic fibrosis or cirrhosis. J Hepatol. 1999;30:472-478.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 192]  [Cited by in F6Publishing: 199]  [Article Influence: 8.0]  [Reference Citation Analysis (0)]
21.  Murakami T, Mochizuki K, Nakamura H. Imaging evaluation of the cirrhotic liver. Semin Liver Dis. 2001;21:213-224.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 37]  [Cited by in F6Publishing: 43]  [Article Influence: 1.9]  [Reference Citation Analysis (0)]
22.  Laghi A, Iannaccone R, Catalano C, Carbone I, Ferrari R, Mangiapane F, Passariello R. Multiphase multislice spiral CT for liver assessment: optimization in cirrhotic patients. Radiol Med. 2002;103:188-195.  [PubMed]  [DOI]  [Cited in This Article: ]
23.  Bernatik T, Strobel D, Hahn EG, Becker D. Doppler measurements: A surrogate marker of liver fibrosis. Eur J Gastroenterol Hepatol. 2002;14:383-387.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 53]  [Cited by in F6Publishing: 59]  [Article Influence: 2.7]  [Reference Citation Analysis (0)]
24.  Martínez-Noguera A, Montserrat E, Torrubia S, Villalba J. Doppler in hepatic cirrhosis and chronic hepatitis. Semin Ultrasound CT MR. 2002;23:19-36.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 50]  [Cited by in F6Publishing: 57]  [Article Influence: 2.6]  [Reference Citation Analysis (0)]
25.  Kok T, van der Jagt EJ, Haagsma EB, Bijleveld CM, Jansen PL, Boeve WJ. The value of Doppler ultrasound in cirrhosis and portal hypertension. Scand J Gastroenterol Suppl. 1999;230:82-88.  [PubMed]  [DOI]  [Cited in This Article: ]
26.  Lonjedo E, Ripollés T. Vascular imaging and interventional procedures in hepatic cirrhosis. Semin Ultrasound CT MR. 2002;23:130-140.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 6]  [Cited by in F6Publishing: 6]  [Article Influence: 0.3]  [Reference Citation Analysis (0)]
27.  Thabut D, Simon M, Myers RP, Messous D, Thibault V, Imbert-Bismut F, Poynard T. Noninvasive prediction of fibrosis in patients with chronic hepatitis C. Hepatology. 2003;37:1220-1221; author reply 1221.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 74]  [Cited by in F6Publishing: 79]  [Article Influence: 3.8]  [Reference Citation Analysis (0)]
28.  Myers RP, Ratziu V, Imbert-Bismut F, Charlotte F, Poynard T. Biochemical markers of liver fibrosis: A comparison with historical features in patients with chronic hepatitis C. Am J Gastroenterol. 2002;97:2419-2425.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 59]  [Cited by in F6Publishing: 63]  [Article Influence: 2.9]  [Reference Citation Analysis (0)]
29.  Prevention and treatment projects of virus hepatitis (tryout) Chin J Intern Med. 1995;34:788-791.  [PubMed]  [DOI]  [Cited in This Article: ]
30.  Flisiak R, Maxwell P, Prokopowicz D, Timms PM, Panasiuk A. Plasma tissue inhibitor of metalloproteinases-1 and transforming growth factor beta 1--possible non-invasive biomarkers of hepatic fibrosis in patients with chronic B and C hepatitis. Hepatogastroenterology. 2002;49:1369-1372.  [PubMed]  [DOI]  [Cited in This Article: ]
31.  Murawaki Y, Nishimura Y, Ikuta Y, Idobe Y, Kitamura Y, Kawasaki H. Plasma transforming growth factor-beta 1 concentrations in patients with chronic viral hepatitis. J Gastroenterol Hepatol. 1998;13:680-684.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 31]  [Cited by in F6Publishing: 34]  [Article Influence: 1.3]  [Reference Citation Analysis (0)]
32.  Walsh KM, Timms P, Campbell S, MacSween RN, Morris AJ. Plasma levels of matrix metalloproteinase-2 (MMP-2) and tissue inhibitors of metalloproteinases -1 and -2 (TIMP-1 and TIMP-2) as noninvasive markers of liver disease in chronic hepatitis C: comparison using ROC analysis. Dig Dis Sci. 1999;44:624-630.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 103]  [Cited by in F6Publishing: 102]  [Article Influence: 4.1]  [Reference Citation Analysis (0)]
33.  Kanzler S, Baumann M, Schirmacher P, Dries V, Bayer E, Gerken G, Dienes HP, Lohse AW. Prediction of progressive liver fibrosis in hepatitis C infection by serum and tissue levels of transforming growth factor-beta. J Viral Hepat. 2001;8:430-437.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 91]  [Cited by in F6Publishing: 89]  [Article Influence: 3.9]  [Reference Citation Analysis (0)]
34.  Pohl A, Behling C, Oliver D, Kilani M, Monson P, Hassanein T. Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection. Am J Gastroenterol. 2001;96:3142-3146.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 196]  [Cited by in F6Publishing: 194]  [Article Influence: 8.4]  [Reference Citation Analysis (0)]
35.  Giannini E, Risso D, Botta F, Chiarbonello B, Fasoli A, Malfatti F, Romagnoli P, Testa E, Ceppa P, Testa R. Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease. Arch Intern Med. 2003;163:218-224.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 236]  [Cited by in F6Publishing: 227]  [Article Influence: 10.8]  [Reference Citation Analysis (0)]
36.  Wong VS, Hughes V, Trull A, Wight DG, Petrik J, Alexander GJ. Serum hyaluronic acid is a useful marker of liver fibrosis in chronic hepatitis C virus infection. J Viral Hepat. 1998;5:187-192.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 98]  [Cited by in F6Publishing: 101]  [Article Influence: 3.9]  [Reference Citation Analysis (0)]
37.  Zheng M, Cai WM, Weng HL, Liu RH. ROC curves in evaluation of serum fibrosis indices for hepatic fibrosis. World J Gastroenterol. 2002;8:1073-1076.  [PubMed]  [DOI]  [Cited in This Article: ]
38.  Chen YP, Feng XR, Dai L, Ding HB, Zhang L. [Screening and evaluation of non-invasive diagnosis markers for compensated liver cirrhosis in patients with chronic hepatitis B]. Zhonghua Ganzangbing Zazhi. 2003;11:225-227.  [PubMed]  [DOI]  [Cited in This Article: ]